Greenwich LifeSciences, Inc.
GLSI· Nasdaq
Released May 20, 2025, after the close
10-Q filed May 20, 2025, 50 days after period end · 0001641172-25-011731
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Net Income | -$2.74M | -$2.47M | -$2.12M | -$1.97M |
| EPS Diluted | -$0.21 | -$0.19 | -$0.17 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Greenwich LifeSciences, Inc. · CIK 1799788 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Mar 31, 2025 · filed May 20, 2025 · 50 d after period end
5.5% from the close of May 20, 2025 to the close of May 21, 2025, the first after the release.